Cargando…

Human Cell Modeling for Cardiovascular Diseases

The availability of appropriate and reliable in vitro cell models recapitulating human cardiovascular diseases has been the aim of numerous researchers, in order to retrace pathologic phenotypes, elucidate molecular mechanisms, and discover therapies using simple and reproducible techniques. In the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lippi, Melania, Stadiotti, Ilaria, Pompilio, Giulio, Sommariva, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503257/ https://www.ncbi.nlm.nih.gov/pubmed/32887493 http://dx.doi.org/10.3390/ijms21176388

Ejemplares similares

Cardiac Biomarkers and Autoantibodies in Endurance Athletes: Potential Similarities with Arrhythmogenic Cardiomyopathy Pathogenic Mechanisms
por: Stadiotti, Ilaria, et al.
Publicado: (2021)

Cell models of arrhythmogenic cardiomyopathy: advances and opportunities
por: Sommariva, Elena, et al.
Publicado: (2017)

Arrhythmogenic Cardiomyopathy: the Guilty Party in Adipogenesis
por: Stadiotti, Ilaria, et al.
Publicado: (2017)

Calcium as a Key Player in Arrhythmogenic Cardiomyopathy: Adhesion Disorder or Intracellular Alteration?
por: Moccia, Francesco, et al.
Publicado: (2019)

Fibrosis in Arrhythmogenic Cardiomyopathy: The Phantom Thread in the Fibro-Adipose Tissue
por: Maione, Angela Serena, et al.
Publicado: (2020)

Human Cardiac Mesenchymal Stromal Cells From Right and Left Ventricles Display Differences in Number, Function, and Transcriptomic Profile
por: Stadiotti, Ilaria, et al.
Publicado: (2020)

Differences in Mitochondrial Membrane Potential Identify Distinct Populations of Human Cardiac Mesenchymal Progenitor Cells
por: Gambini, Elisa, et al.
Publicado: (2020)

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
por: Pilato, Chiara Assunta, et al.
Publicado: (2018)

Cyclophilin A in Arrhythmogenic Cardiomyopathy Cardiac Remodeling
por: Rurali, Erica, et al.
Publicado: (2019)

Excess TGF-β1 Drives Cardiac Mesenchymal Stromal Cells to a Pro-Fibrotic Commitment in Arrhythmogenic Cardiomyopathy
por: Maione, Angela Serena, et al.
Publicado: (2021)

Pressure Overload Activates DNA-Damage Response in Cardiac Stromal Cells: A Novel Mechanism Behind Heart Failure With Preserved Ejection Fraction?
por: Stadiotti, Ilaria, et al.
Publicado: (2022)

From bedside to the bench: patient-specific hiPSC-EC models uncover endothelial dysfunction in genetic cardiomyopathies
por: Rabino, Martina, et al.
Publicado: (2023)

Clinical and Molecular Data Define a Diagnosis of Arrhythmogenic Cardiomyopathy in a Carrier of a Brugada-Syndrome-Associated PKP2 Mutation
por: Persampieri, Simone, et al.
Publicado: (2020)

Modeling Cardiomyopathies in a Dish: State-of-the-Art and Novel Perspectives on hiPSC-Derived Cardiomyocytes Maturation
por: Lodola, Francesco, et al.
Publicado: (2021)

Omics Analyses of Stromal Cells from ACM Patients Reveal Alterations in Chromatin Organization and Mitochondrial Homeostasis
por: Lippi, Melania, et al.
Publicado: (2023)

Spectrum of Rare and Common Genetic Variants in Arrhythmogenic Cardiomyopathy Patients
por: Lippi, Melania, et al.
Publicado: (2022)

The Endocannabinoid System and Cannabidiol: Past, Present, and Prospective for Cardiovascular Diseases
por: Rabino, Martina, et al.
Publicado: (2021)

Myocardial Inflammation as a Manifestation of Genetic Cardiomyopathies: From Bedside to the Bench
por: Peretto, Giovanni, et al.
Publicado: (2023)

The arrhythmogenic cardiomyopathy-specific coding and non-coding transcriptome in human cardiac stromal cells
por: Rainer, Johannes, et al.
Publicado: (2018)

Human Hematopoietic Stem/Progenitor Cells in Type One Diabetes Mellitus Treatment: Is There an Ideal Candidate?
por: Carulli, Ermes, et al.
Publicado: (2023)

Patient-specific primary and pluripotent stem cell-derived stromal cells recapitulate key aspects of arrhythmogenic cardiomyopathy
por: Maione, Angela Serena, et al.
Publicado: (2023)

GCN5 contributes to intracellular lipid accumulation in human primary cardiac stromal cells from patients affected by Arrhythmogenic cardiomyopathy
por: Volani, Chiara, et al.
Publicado: (2022)

Derivation of human induced pluripotent stem cell line EURACi004-A from skin fibroblasts of a patient with Arrhythmogenic Cardiomyopathy carrying the heterozygous PKP2 mutation c.2569_3018del50
por: Ermon, Benedetta, et al.
Publicado: (2018)

Presence of SARS-CoV-2 Nucleoprotein in Cardiac Tissues of Donors with Negative COVID-19 Molecular Tests
por: Perrucci, Gianluca Lorenzo, et al.
Publicado: (2021)

MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathy
por: Sommariva, Elena, et al.
Publicado: (2017)

Human induced pluripotent stem cell for modeling cardiovascular diseases
por: Liang, Ping, et al.
Publicado: (2014)

“Betwixt Mine Eye and Heart a League Is Took”: The Progress of Induced Pluripotent Stem-Cell-Based Models of Dystrophin-Associated Cardiomyopathy
por: Rovina, Davide, et al.
Publicado: (2020)

Evidence of SARS-CoV-2 Transcriptional Activity in Cardiomyocytes of COVID-19 Patients without Clinical Signs of Cardiac Involvement
por: Bulfamante, Gaetano Pietro, et al.
Publicado: (2020)

The ESC Working Group on cardiovascular regenerative and reparative medicine
por: Pompilio, Giulio, et al.
Publicado: (2023)

Cyclophilin A: a key player for human disease
por: Nigro, P, et al.
Publicado: (2013)

Cardiovascular Calcification as a Marker of Increased Cardiovascular Risk and a Surrogate for Subclinical Atherosclerosis: Role of Echocardiography
por: Faggiano, Andrea, et al.
Publicado: (2021)

Recent advances in managing human papillomavirus-positive oropharyngeal tumors
por: Cantu, Giulio, et al.
Publicado: (2010)

In Vitro Epigenetic Reprogramming of Human Cardiac Mesenchymal Stromal Cells into Functionally Competent Cardiovascular Precursors
por: Vecellio, Matteo, et al.
Publicado: (2012)

Metabolic Signature of Arrhythmogenic Cardiomyopathy
por: Volani, Chiara, et al.
Publicado: (2021)

The Representative Porcine Model for Human Cardiovascular Disease
por: Suzuki, Yoriyasu, et al.
Publicado: (2011)

Effects of canagliflozin on human myocardial redox signalling: clinical implications
por: Kondo, Hidekazu, et al.
Publicado: (2021)

Epidemiology and cardiovascular risk factors of aortic stenosis
por: Faggiano, Pompilio, et al.
Publicado: (2006)

Editorial: Exploring the Crosstalk Between Adipose Tissue and the Cardiovascular System
por: Badi, Ileana, et al.
Publicado: (2022)

Ca(2+) dysregulation in cardiac stromal cells sustains fibro-adipose remodeling in Arrhythmogenic Cardiomyopathy and can be modulated by flecainide
por: Maione, Angela S., et al.
Publicado: (2022)

Cardiac mesenchymal stromal cells are a source of adipocytes in arrhythmogenic cardiomyopathy
por: Sommariva, E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_177df2aak2u8b041smj83crjk2